These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 291746)

  • 1. Immune response to melanoma extracts in three melanoma-prone families.
    Vandenbark AA; Greene MH; Burger DR; Vetto RM; Reimer RR
    J Natl Cancer Inst; 1979 Nov; 63(5):1147-51. PubMed ID: 291746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic abnormalities in melanoma-prone families.
    Dean JH; Greene MH; Reimer RR; LeSane FV; McKeen EA; Mulvihill JJ; Blattner WA; Herberman RB; Fraumeni JF
    J Natl Cancer Inst; 1979 Nov; 63(5):1139-45. PubMed ID: 159376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological basis of close-contact sensitization to osteosarcoma.
    Powell A; Sloss AM; Makley JT
    Cancer Res; 1979 Feb; 39(2 Pt 2):658-9. PubMed ID: 310710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunologic response in patients with melanoma of the skin].
    Mutsenietse AIa; Volrat AA; Popena BA; Bumbieris IaV; Shapovalova EA
    Vopr Onkol; 1983; 29(4):34-8. PubMed ID: 6858048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemocytometer leukocyte adherence inhibition technique.
    Maluish AE; Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of antitumor immunity in patients with larynx cancer by tube leukocyte adherence inhibition assay.
    Holán V; Síbl O; Hasek M
    Cancer Res; 1979 Feb; 39(2 Pt 2):651-3. PubMed ID: 761230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure.
    Briollais L; Chompret A; Guilloud-Bataille M; Bressac-de Paillerets B; Avril MF; Demenais F
    Int J Epidemiol; 2000 Jun; 29(3):408-15. PubMed ID: 10869311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further study of specific immunoreactivity in patients with malignant melanoma of uveal tissue by LAI assay.
    Kalafut F; Cernák A
    Neoplasma; 1982; 29(5):561-6. PubMed ID: 7177245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor immune response to colorectal cancer antigen detected by the leukocyte adherence inhibition test (LAI) in groups at high risk for colorectal cancer.
    Shani A; Fink A; Bass D; Gottesfeld F; Becker S; Levy E; Bentwich Z; Rozen P; Fireman Z; Hallak A
    Cancer Detect Prev; 1986; 9(5-6):485-90. PubMed ID: 3779710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
    Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cell-mediated immunity in patients with malignant melanoma.
    Fixa B; Komárková O; Kraus Z; Simková H
    Neoplasma; 1978; 25(3):353-7. PubMed ID: 683378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'.
    Clark WH; Reimer RR; Greene M; Ainsworth AM; Mastrangelo MJ
    Arch Dermatol; 1978 May; 114(5):732-8. PubMed ID: 646394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
    Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
    Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.